These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 10316675)

  • 1. What is a good drug?
    Owen JA
    Hosp Formul; 1975 Mar; 10(3):108. PubMed ID: 10316675
    [No Abstract]   [Full Text] [Related]  

  • 2. How good are our drugs?
    Miller LC
    Am J Hosp Pharm; 1970 May; 27(5):367-74. PubMed ID: 5422276
    [No Abstract]   [Full Text] [Related]  

  • 3. The importance of drug standards.
    Heller WM
    Am J Hosp Pharm; 1982 Apr; 39(4):652-3. PubMed ID: 7081247
    [No Abstract]   [Full Text] [Related]  

  • 4. Drug standards--communication and revision.
    Barnstein CH
    J Parenter Drug Assoc; 1979; 33(5):237-8. PubMed ID: 259643
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmaceutical analysis: key to drug quality and control.
    Florey KG; Brewer GA
    Am Pharm; 1981 Aug; NS21(8):30-5. PubMed ID: 7270421
    [No Abstract]   [Full Text] [Related]  

  • 6. USP and the Drug Regulation Reform Act.
    Heller WM
    J Parenter Drug Assoc; 1979; 33(2):55-60. PubMed ID: 255147
    [No Abstract]   [Full Text] [Related]  

  • 7. Reporting drug defects.
    Belson JJ
    Hosp Formul; 1975 Feb; 10(2):78-9. PubMed ID: 10316674
    [No Abstract]   [Full Text] [Related]  

  • 8. Relationship of USP-NF to NDA and ANDA "Standards".
    Belson JJ
    Am J Hosp Pharm; 1982 May; 39(5):869-70. PubMed ID: 7081269
    [No Abstract]   [Full Text] [Related]  

  • 9. USP general chapter <797> pharmaceutical compounding-sterile preparations.
    Hung JC
    J Nucl Med; 2004 Jun; 45(6):20N, 28N. PubMed ID: 15181114
    [No Abstract]   [Full Text] [Related]  

  • 10. Drug product equivalence--the problem, the challenge, and the U.S.P.
    Macek TJ
    Am J Pharm Sci Support Public Health; 1971; 143(6):188-94. PubMed ID: 5140167
    [No Abstract]   [Full Text] [Related]  

  • 11. "Who shall establish drug standards"?
    Macek TJ
    J Am Pharm Assoc; 1973 Mar; 13(3):122-3. PubMed ID: 4689929
    [No Abstract]   [Full Text] [Related]  

  • 12. Voluntary standards--the USP and the PDA.
    Schmitz AJ
    J Parenter Drug Assoc; 1980; 34(6):425-6. PubMed ID: 6906364
    [No Abstract]   [Full Text] [Related]  

  • 13. Drug standards laboratory enters second decade.
    Reese KM
    J Am Pharm Assoc; 1972 Jan; 12(1):16-20. PubMed ID: 5007258
    [No Abstract]   [Full Text] [Related]  

  • 14. Drug product equivalence--are specifications necessary?
    Bergen JV
    J Am Pharm Assoc; 1972 Jan; 12(1):21-5. PubMed ID: 5007259
    [No Abstract]   [Full Text] [Related]  

  • 15. [Fifth supplement to the United States Pharmacopoeia XIX and National Formulary XIV].
    Montanari L
    Boll Chim Farm; 1979 Oct; 118(10):585-93. PubMed ID: 553525
    [No Abstract]   [Full Text] [Related]  

  • 16. Standards for particulate matter in all parenteral drug products.
    Jeffrey LP; Pinkus TF
    Am J Hosp Pharm; 1976 Sep; 33(9):879-80. PubMed ID: 984053
    [No Abstract]   [Full Text] [Related]  

  • 17. USP standards.
    Banes D
    Am J Hosp Pharm; 1976 Dec; 33(12):1245. PubMed ID: 998641
    [No Abstract]   [Full Text] [Related]  

  • 18. An epic decision by USP.
    Provost GP
    J Am Pharm Assoc; 1977 Sep; 17(9):547. PubMed ID: 893923
    [No Abstract]   [Full Text] [Related]  

  • 19. Particulate matter standards for small-volume injections.
    Belson JJ
    Am J Hosp Pharm; 1986 Jun; 43(6):1527-8. PubMed ID: 3728492
    [No Abstract]   [Full Text] [Related]  

  • 20. [ICH4 and pharmacopoeias: similarities and differences].
    Artiges A
    Ann Pharm Fr; 1999 Mar; 57(2):161-7. PubMed ID: 10365473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.